Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Diseases
About This Trial
- This research study is collecting and safely storing blood and tissue samples to help scientists better understand cancers, including prostate cancer.
- It is open to people who have or are suspected of having cancer, as well as their close blood relatives.
- If you choose to take part, the study team will collect periodic blood samples and keep small samples of tissue if you undergo surgery.
- Participating does not involve testing a new medical treatment, but your donated samples will support ongoing research to improve cancer care for future patients.
More Information
- Selected individuals suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI.
- Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease.
- These samples will be stored in the tissue bank of the Urologic Oncology Branch.
- Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI.
- These materials will be used in the research efforts of the Urologic Oncology Branch, NCI.
Who Can Enroll
- Age Range: 2 years and older
- Gender: All
- Who This Trial is For: This research study is collecting and safely storing blood and tissue samples to help scientists better understand cancers, including prostate cancer.
Study Details
- Start Date: March 12, 1998
- Lead Sponsor: National Cancer Institute (NCI)
Full Eligibility Criteria
- INCLUSION CRITERIA:
- Individuals with biopsy-proven malignant disease
- Individuals suspected of having a malignant disease
- Individuals who have or are suspected of having an inherited genitourinary malignant disorder
- Participants must be >= 2 years of age
- A relative (related by blood) of an individual with a confirmed or suspected diagnosis of a malignant disease or an inherited genitourinary malignant disorder.
- All participants and parents/guardians, for children younger than 18 years of age, must sign an informed consent document indicating their understanding of the investigational nature and the risks of this study before any protocol related studies are performed.
Exclusion Criteria
- Individuals whose co-morbidities preclude surgical intervention.